Zoetis (ZTS)
$125.62
1.35 (1.09%)
ZTS Stock Quote Delayed 15 Minutes
Previous Close
$125.62
Market Cap
60.78B
PE Ratio
63.13
EPS
1.99
Volume (Avg. Vol.)
2.59M
Day's Range
124.64 - 126.14
52-Week Range
78.90 - 130.08
Dividend & Yield
0.38 (0.30%)
ZTS Stock Predictions, Articles, and Zoetis News
10 Pharmaceuticals Stocks to Buy Now
The grades of 10 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Valeant Pharmaceuticals Intl Inc’s Hard Times Mean Avoid VRX Stock
Investors and analysts are raising their eyebrows over some strange goings on at Valeant Pharmaceuticals, leading to our bear call on VRX stock
41 Trades To Make Before May Ends
During these times it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 41 trades
60 Upgrades and Downgrades for the Week
During these times, it pays to stay on top of the latest profit opportunities. Today's post is a great place to start with updated rankings for 60 stocks
Prepare for Earnings Season with These 49 Trades
It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 49 trades to consider
73 Stock Trades for Your Week
During these times it pays to stay on top of the latest profit opportunities. Today's blog post should be a great place to start with these 73 stock trades
53 Trades to Stay Ahead of the Curve
During these times it pays to stay on top of the latest profit opportunities. Today's blog post should is a great place to start with our updated rankings
Prepare For the Rush With These 41 Dividend Stocks
In this low interest rate environment, dividends are still looking great. Here is a list of 44 dividend stocks set for payouts this quarter
Amgen, Boeing, Pfizer Lead 12 Dividend Stocks Increasing Payouts
Among the leading companies moving to make shareholders happy last week was a mega-cap biotechnology giant, a mammoth defense and aerospace contractor, the biggest drug retailer in the world and a Big Pharma behemoth.
63 Trades to Kick Off the Week
During these busy times, it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start.
55 Trades to Make this Week
Today's blog post is a great place to start looking for those stock we have listed to both buy and sell based on the Portfolio Grader model.
ZTS: A Market Leader That Looks Ready to Soar Higher
Zoetis is a dominant market leader with decided scale advantages over its peers, operating in an industry with clear macro tailwinds. ZTS stock is a good buy at this level.
Trade of the Day: Zoetis (ZTS)
I want to clue you in on one of the equities I have a position in my Trader's Advantage service.
9 Pharmaceutical Stocks to Buy Now
This week, nine pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
10 Pharmaceutical Stocks to Buy Now
The grades of 10 pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
45 Blue-Chip Dividend Stocks That Increased Payouts in Q4 2014
Dividend stocks in just about every sector thrilled investors with meaningful payout raises in Q4. Here's a look at 45 of the biggest blue chips to up the ante.
Dow Stars, Biotech Lead 13 Dividend Stocks Increasing Payouts
The central bank’s “patience” stance when it comes to future interest rate hikes was a present to the bulls, and the result was a week of pre-holiday stock market revelry. Here are 13 stocks increasing dividends.
Mergers and Acquisitions: Zoetis a Buy on Ackman Stake
Zoetis stock likely has more upside to come now that activist investor Bill Ackman has put it in play by building a $2 billion stake.
How to Invest in IPOs via Mutual Funds and ETFs
It's difficult to learn how to invest in IPOs. However, some mutual funds and ETFs give investors entry to new issues like the Alibaba IPO.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
